Literature DB >> 18848647

Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.

Ted R Mikuls1, Jeffrey B Payne, Richard A Reinhardt, Geoffrey M Thiele, Eileen Maziarz, Amy C Cannella, V Michael Holers, Kristine A Kuhn, James R O'Dell.   

Abstract

UNLABELLED: Antibody titers to P. gingivalis are increased in patients with rheumatoid arthritis and are associated with disease-specific autoimmunity.
BACKGROUND: Periodontitis (PD) has been implicated as a risk factor for rheumatoid arthritis (RA). We sought to characterize antibody titers to P. gingivalis (a pathogen in PD) in subjects with RA, PD, and in healthy controls and to examine their relationship with disease autoantibodies.
METHODS: P. gingivalis antibody was measured in subjects with RA (n=78), PD (n=39), and in controls (n=40). Group frequencies of bacterial titer elevations were compared using the Chi-square test and antibody titers were compared using non-parametric tests. Correlations of P. gingivalis titer with C-reactive protein (CRP), antibody to cyclic citrullinated peptide (anti-CCP), and rheumatoid factor (RF) were examined in those with RA while CRP and autoantibody concentrations were compared based on seropositivity to P. gingivalis.
RESULTS: Antibody titers to P. gingivalis were highest in PD, lowest in controls, and intermediate in RA (p=0.0003). Elevations in P. gingivalis (titer> or =800) were more common in RA and PD (67% and 77%, respectively) than in controls (40%) (p=0.002). In RA, there were significant correlations with P. gingivalis titer with CRP, anti-CCP-IgM, and -IgG-2. CRP (p=0.006), anti-CCP-IgM (p=0.01) and -IgG2 (p=0.04) concentrations were higher in RA cases with P. gingivalis titers > or =800 compared to cases with titers <800.
CONCLUSION: Antibodies to P. gingivalis are more common in RA subjects than controls, although lower than that in PD. Associations of P. gingivalis titers with RA-related autoantibody and CRP concentrations suggests that infection with this organism plays a role in disease risk and progression in RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848647      PMCID: PMC2748386          DOI: 10.1016/j.intimp.2008.09.008

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  48 in total

1.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

2.  Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.

Authors:  L M Golub; H M Lee; G Lehrer; A Nemiroff; T F McNamara; R Kaplan; N S Ramamurthy
Journal:  J Periodontal Res       Date:  1983-09       Impact factor: 4.419

3.  Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.

Authors:  J R O'Dell; C E Haire; W Palmer; W Drymalski; S Wees; K Blakely; M Churchill; P J Eckhoff; A Weaver; D Doud; N Erikson; F Dietz; R Olson; P Maloley; L W Klassen; G F Moore
Journal:  Arthritis Rheum       Date:  1997-05

4.  Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase.

Authors:  W T McGraw; J Potempa; D Farley; J Travis
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Teeth loss and the inflammation of teeth-supporting tissues in rheumatoid disease.

Authors:  M Malmström; P E Calonius
Journal:  Scand J Rheumatol       Date:  1975       Impact factor: 3.641

7.  Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.

Authors:  Anne Havemose-Poulsen; Jytte Westergaard; Kaj Stoltze; Henrik Skjødt; Bente Danneskiold-Samsøe; Henning Locht; Klaus Bendtzen; Palle Holmstrup
Journal:  J Periodontol       Date:  2006-02       Impact factor: 6.993

8.  Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins.

Authors:  A J Silman; J Newman; A J MacGregor
Journal:  Arthritis Rheum       Date:  1996-05

Review 9.  Inter-relationships between rheumatoid arthritis and periodontal disease. A review.

Authors:  F B Mercado; R I Marshall; P M Bartold
Journal:  J Clin Periodontol       Date:  2003-09       Impact factor: 8.728

10.  Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.

Authors:  Annette H M van der Helm-van Mil; Kirsten N Verpoort; Ferdinand C Breedveld; René E M Toes; Tom W J Huizinga
Journal:  Arthritis Res Ther       Date:  2005-06-14       Impact factor: 5.156

View more
  97 in total

1.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

2.  Expression of human and Porphyromonas gingivalis glutaminyl cyclases in periodontitis and rheumatoid arthritis-A pilot study.

Authors:  Philip Bender; Andreas Egger; Martin Westermann; Nadine Taudte; Anton Sculean; Jan Potempa; Burkhard Möller; Mirko Buchholz; Sigrun Eick
Journal:  Arch Oral Biol       Date:  2018-10-28       Impact factor: 2.633

Review 3.  The microbiome and rheumatoid arthritis.

Authors:  Jose U Scher; Steven B Abramson
Journal:  Nat Rev Rheumatol       Date:  2011-08-23       Impact factor: 20.543

Review 4.  Environmental and gene-environment interactions and risk of rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Kevin Deane
Journal:  Rheum Dis Clin North Am       Date:  2012-05-30       Impact factor: 2.670

5.  Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.

Authors:  Song Li; Yangsheng Yu; Yinshi Yue; Hongyan Liao; Wanqin Xie; Jessica Thai; Ted R Mikuls; Geoffrey M Thiele; Michael J Duryee; Harlan Sayles; Jeffrey B Payne; Lynell W Klassen; James R O'Dell; Zhixin Zhang; Kaihong Su
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

Review 6.  Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions.

Authors:  Clifton O Bingham; Malini Moni
Journal:  Curr Opin Rheumatol       Date:  2013-05       Impact factor: 5.006

Review 7.  Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis - a systematic review and meta-analysis.

Authors:  Philip Bender; Walter B Bürgin; Anton Sculean; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2016-08-25       Impact factor: 3.573

Review 8.  Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?

Authors:  Jose U Scher; Walter A Bretz; Steven B Abramson
Journal:  Curr Opin Rheumatol       Date:  2014-07       Impact factor: 5.006

Review 9.  The association between rheumatoid arthritis and periodontal disease.

Authors:  Jacqueline Detert; Nicole Pischon; Gerd R Burmester; Frank Buttgereit
Journal:  Arthritis Res Ther       Date:  2010-10-22       Impact factor: 5.156

Review 10.  Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Authors:  Pamela Mangat; Natalia Wegner; Patrick J Venables; Jan Potempa
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.